TYBR is a medical device company developing a sprayable hydrogel to keep internal organs scar-free after surgery.
TYBR Health has raised $30.0M in total funding. The most recent round was Series A. The last funding was announced in July 2026.
TYBR Health's investors include Y Combinator, Vensana Capital, Mutual Capital Partners, Asymmetry Ventures, Eight Capital.
TYBR Health is headquartered in Houston, United States.
TYBR is a medical device company developing a sprayable hydrogel to keep internal organs scar-free after surgery.
TYBR Health is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"TYBR Health — Funding & Investors." VCBacked, July 21, 2026, https://www.vcbacked.co/company/tybr-health. Accessed September 7, 2026.
VCBacked. (2026). TYBR Health — Funding & Investors. Retrieved September 7, 2026, from https://www.vcbacked.co/company/tybr-health
{{cite web |title=TYBR Health — Funding & Investors |url=https://www.vcbacked.co/company/tybr-health |website=VCBacked |access-date=September 7, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated